BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 33197579)

  • 1. The prevalence and incidence rate of pulmonary arterial hypertension in systemic sclerosis: Systematic review and meta-analysis.
    Rubio-Rivas M; Homs NA; Cuartero D; Corbella X
    Autoimmun Rev; 2021 Jan; 20(1):102713. PubMed ID: 33197579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status.
    Simeón-Aznar CP; Fonollosa-Plá V; Tolosa-Vilella C; Espinosa-Garriga G; Ramos-Casals M; Campillo-Grau M; García-Hernández FJ; Castillo-Palma MJ; Sánchez-Román J; Callejas-Rubio JL; Ortego-Centeno N; Egurbide-Arberas MV; Trapiellla-Martínez L; Gallego-Villalobos M; Sáez-Comet L; Velilla-Marco J; Camps-García MT; de Ramón-Garrido E; Esteban Marcos EM; Pallarés-Ferreres L; Hidalgo-Tenorio C; Sabio-Sánchez JM; Gómez-de la Torre R; Salvador-Cervello G; Rios-Blanco JJ; Gil-Aguado A; Vilardell-Tarrés M
    Semin Arthritis Rheum; 2012 Jun; 41(6):789-800. PubMed ID: 22169458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary arterial hypertension and systemic sclerosis relation: a single centre experience.
    Demir N; Şahin A; Küçükşahin O; Kayacan O; Dinçer İ; Sayın T; Karnak D; Turgay M
    Heart Lung Circ; 2014 Jul; 23(7):667-73. PubMed ID: 24613044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial injury assessed with functional techniques in systemic sclerosis patients with pulmonary arterial hypertension versus systemic sclerosis patients without pulmonary arterial hypertension: a systematic review and meta-analysis.
    Theodorakopoulou MP; Minopoulou I; Sarafidis P; Kamperidis V; Papadopoulos C; Dimitroulas T; Boutou AK
    Rheumatol Int; 2021 Jun; 41(6):1045-1053. PubMed ID: 33830321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The incidence rate of pulmonary arterial hypertension and scleroderma renal crisis in systemic sclerosis patients with digital ulcers on endothelin antagonist receptors (ERAs) and phosphodiesterase-5 inhibitors (PDE5i).
    Pestaña-Fernández M; Rubio-Rivas M; Tolosa-Vilella C; Guillén-Del-Castillo A; Colunga-Argüelles D; Argibay A; Marí-Alfonso B; Marín-Ballvé A; Pla-Salas X; Chamorro AJ; Castro-Salomó A; Madroñero-Vuelta AB; Sánchez-García ME; Sáez-Comet L; González-Echávarri C; Ortego-Centeno N; Vargas-Hitos JA; Todolí-Parra JA; Trapiella-Martínez L; Lledó GM; Freire M; Fonollosa-Pla V; Simeón-Aznar CP;
    Rheumatology (Oxford); 2021 Feb; 60(2):872-880. PubMed ID: 32844220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic sclerosis sine scleroderma: a multicenter study of 1417 subjects.
    Diab S; Dostrovsky N; Hudson M; Tatibouet S; Fritzler MJ; Baron M; Khalidi N;
    J Rheumatol; 2014 Nov; 41(11):2179-85. PubMed ID: 25274885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence, prevalence and long-term progression of Goh algorithm rated interstitial lung disease in systemic sclerosis in two independent cohorts in flanders: A retrospective cohort study.
    Vandecasteele E; Melsens K; Vanhaecke A; Blockmans D; Bonroy C; Carton C; Deschepper E; De Keyser F; Houssiau F; Piette Y; Vanthuyne M; Verbeke K; Westhovens R; Wuyts WA; De Langhe E; Brusselle G; Smith V
    Semin Arthritis Rheum; 2021 Oct; 51(5):969-976. PubMed ID: 34403812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and predictors of pulmonary artery hypertension in systemic sclerosis.
    Kumar U; Ramteke R; Yadav R; Ramam M; Handa R; Kumar A
    J Assoc Physicians India; 2008 Jun; 56():413-7. PubMed ID: 18822619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for the early detection of pulmonary arterial hypertension in patients with systemic sclerosis: A systematic review and meta-analysis of long-term outcomes.
    Brown Z; Proudman S; Morrisroe K; Stevens W; Hansen D; Nikpour M
    Semin Arthritis Rheum; 2021 Jun; 51(3):495-512. PubMed ID: 33857705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The heart and pulmonary arterial hypertension in systemic sclerosis.
    Vandecasteele EH; De Pauw M; Brusselle G; Decuman S; Piette Y; De Keyser F; Smith V
    Acta Clin Belg; 2016 Feb; 71(1):1-18. PubMed ID: 27075793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for pulmonary arterial hypertension in patients with scleroderma--a New Zealand perspective.
    Ghosh SK; Corkill MM; Hart HH; Ng KP
    N Z Med J; 2014 Aug; 127(1400):30-8. PubMed ID: 25145365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for development of pulmonary arterial hypertension in Australian systemic sclerosis patients: results from a large multicenter cohort study.
    Morrisroe K; Huq M; Stevens W; Rabusa C; Proudman SM; Nikpour M;
    BMC Pulm Med; 2016 Sep; 16(1):134. PubMed ID: 27677579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon and alternative activation of monocyte/macrophages in systemic sclerosis-associated pulmonary arterial hypertension.
    Christmann RB; Hayes E; Pendergrass S; Padilla C; Farina G; Affandi AJ; Whitfield ML; Farber HW; Lafyatis R
    Arthritis Rheum; 2011 Jun; 63(6):1718-28. PubMed ID: 21425123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2013 ACR/EULAR systemic sclerosis classification criteria in patients with associated pulmonary arterial hypertension.
    Joven BE; Escribano P; Andreu JL; Loza E; Jimenez C; de Yebenes MJG; Ruiz-Cano MJ; Carmona L; Carreira PE
    Semin Arthritis Rheum; 2018 Jun; 47(6):870-876. PubMed ID: 29126717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subclinical coronary atherosclerosis, detected by computer tomography with coronary calcium score, and the occurrence of major cardiovascular events at 5 years of follow-up in a cohort of patients with systemic sclerosis.
    Rotondo C; Sciacca S; Rella V; Busto G; Colia R; Cantatore FP; Corrado A
    Eur J Intern Med; 2023 Sep; 115():62-69. PubMed ID: 37316356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nailfold Capillaroscopy in Systemic Sclerosis Patients with and without Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis.
    Minopoulou I; Theodorakopoulou M; Boutou A; Arvanitaki A; Pitsiou G; Doumas M; Sarafidis P; Dimitroulas T
    J Clin Med; 2021 Apr; 10(7):. PubMed ID: 33917407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence, predictors, and survival of pulmonary hypertension determined by echocardiography in Thai patients with early systemic sclerosis (SSc): inception cohort study.
    Wangkaew S; Pota P; Prasertwittayakij N; Phrommintikul A
    Clin Rheumatol; 2021 Mar; 40(3):973-980. PubMed ID: 32683661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Red blood cell distribution width as a related factor of pulmonary arterial hypertension in patients with systemic sclerosis.
    Zhao J; Mo H; Guo X; Wang Q; Xu D; Hou Y; Tian Z; Liu Y; Wang H; Lai J; Li M; Zeng X
    Clin Rheumatol; 2018 Apr; 37(4):979-985. PubMed ID: 29164429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of key genes and immune profile in limited cutaneous systemic sclerosis-associated pulmonary arterial hypertension by bioinformatics analysis.
    Zhang T; Huang C; Luo H; Li J; Huang H; Liu X; Zhan S
    Life Sci; 2021 Apr; 271():119151. PubMed ID: 33539912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Digital ulcers and cutaneous subsets of systemic sclerosis: Clinical, immunological, nailfold capillaroscopy, and survival differences in the Spanish RESCLE Registry.
    Tolosa-Vilella C; Morera-Morales ML; Simeón-Aznar CP; Marí-Alfonso B; Colunga-Arguelles D; Callejas Rubio JL; Rubio-Rivas M; Freire-Dapena M; Guillén-Del Castillo A; Iniesta-Arandia N; Castillo-Palma MJ; Egurbide-Arberas M; Trapiellla-Martínez L; Vargas-Hitos JA; Todolí-Parra JA; Rodriguez-Carballeira M; Marin-Ballvé A; Pla-Salas X; Rios-Blanco JJ; Fonollosa-Pla V;
    Semin Arthritis Rheum; 2016 Oct; 46(2):200-208. PubMed ID: 27312381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.